Skip to main content
Fig. 3 | BMC Pregnancy and Childbirth

Fig. 3

From: Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study

Fig. 3

Screening for the factors associated with treatment response (in 2 weeks). Forest plot based on univariate analysis for maternal baseline characteristics and baseline blood values as potential risk factors. BMI: body mass index; MPV: mean platelet volume; PDW: platelet distribution width; P-LCR: platelet-large cell ratio; PLR: platelet-lymphocyte ratio

Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us